Used in pharmaceutical research as a key intermediate in the synthesis of neuroactive compounds, particularly those targeting central nervous system disorders. Its structural framework supports the development of ligands for neurotransmitter receptors, including serotonin and dopamine receptors. Commonly employed in the preparation of experimental drugs aimed at treating depression, anxiety, and cognitive impairments. Also utilized in the design of novel bicyclic analogs for structure-activity relationship studies in medicinal chemistry.